Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence

Ling, Walter · 1996 · Archives of General Psychiatry

Abstract

BACKGROUND: Buprenorphine is a partial agonist at the mu-opioid receptor that has been proposed as an alternative to traditional full agonist maintenance therapy for the treatment of opioid addiction. We report on a clinical trial in which the relative safety and efficacy of long-term fixed-dose buprenorphine maintenance was examined in comparison to low- and high-dose methadone maintenance. METHODS: Two hundred twenty-five treatment-seeking opioid addicts (46 women, 179 men) were randomly assigned to receive, in a double-blind manner, either 8 mg/d of buprenorphine, 30 mg/d of methadone, or 80 mg/d of methadone maintenance over a 1-year period. Objective and subjective measures of efficacy (urine toxicology, retention, craving, and withdrawal symptoms) were examined at the study midpoint and at termination, and safety data were tabulated over the entire 52-week study period. RESULTS: Patients assigned to high-dose methadone maintenance performed significantly better on measures of retention, opioid use, and opioid craving than either the low-dose methadone or the buprenorphine group at both 26-week and 52-week time points. Performance on these measures was virtually identical between the latter two groups. No serious adverse health effects attributable to buprenorphine were noted. CONCLUSIONS: Buprenorphine maintenance at 8 mg/d appears to be less than optimally efficacious under the conditions of the present study. Continued research is needed to reconcile these findings with the more positive results reported by other investigative groups. There are no apparent health risks associated with long-term buprenorphine maintenance at this dosage.

Overview

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1996.01830050035005

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Cited by

See all 401

Metadata

Authors
Ling, W.
Corresponding author
Ling, Walter
Venue
Archives of General Psychiatry
Published
1996-05-01
Volume
53
Issue
5
Pages
401
ISSN
0003-990X (ISSN-L)
OpenAlex
W1980315117
Cited by
366
References
20
Citations by year
2025: 3 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 12 · 2012: 18
FWCI
16.73
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of General Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r18da006082-05)
  • National Institute on Drug Abuse (R18 DA6082)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
buprenorphine, methadone maintenance treatment, opioid use disorder, opioid dependence treatment, treatment retention, opioid craving, withdrawal symptoms, drug use, treatment efficacy, drug safety, dose comparison
MeSH terms
Adult, Buprenorphine, Cocaine, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Heroin Dependence, Humans, Male, Methadone, Opioid-Related Disorders, Placebos, Substance Abuse Detection, Treatment Outcome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence. https://app.cochat.ai/papers/10.1001/archpsyc.1996.01830050035005
The paper
Ling, W. (1996). A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1996.01830050035005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.